ES397035A1 - Antiinflammatory preparations - Google Patents
Antiinflammatory preparationsInfo
- Publication number
- ES397035A1 ES397035A1 ES397035A ES397035A ES397035A1 ES 397035 A1 ES397035 A1 ES 397035A1 ES 397035 A ES397035 A ES 397035A ES 397035 A ES397035 A ES 397035A ES 397035 A1 ES397035 A1 ES 397035A1
- Authority
- ES
- Spain
- Prior art keywords
- coprecipitate
- lignosulfonate
- inflammatory agent
- antiinflammatory
- preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A process for preparing a coprecipitate of an anti-inflammatory agent and a lignosulfonate, characterized in that an aqueous basic solution of an anti-inflammatory agent and a lignosulfonate is acidified, and then the coprecipitate is isolated by suitable means. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8999970A | 1970-11-16 | 1970-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES397035A1 true ES397035A1 (en) | 1975-03-01 |
Family
ID=22220596
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES397035A Expired ES397035A1 (en) | 1970-11-16 | 1971-11-15 | Antiinflammatory preparations |
ES422331A Expired ES422331A1 (en) | 1970-11-16 | 1974-01-16 | Antiinflammatory preparations |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES422331A Expired ES422331A1 (en) | 1970-11-16 | 1974-01-16 | Antiinflammatory preparations |
Country Status (16)
Country | Link |
---|---|
AT (1) | AT313468B (en) |
AU (1) | AU461558B2 (en) |
BE (1) | BE775255A (en) |
BR (1) | BR7107569D0 (en) |
CA (1) | CA994241A (en) |
CH (1) | CH557177A (en) |
DE (1) | DE2156915A1 (en) |
DK (1) | DK132485C (en) |
ES (2) | ES397035A1 (en) |
FI (1) | FI51048C (en) |
FR (1) | FR2113976B1 (en) |
GB (1) | GB1345358A (en) |
IE (1) | IE36030B1 (en) |
IL (1) | IL38003A (en) |
NL (1) | NL7115198A (en) |
ZA (1) | ZA717652B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1335259C (en) * | 1989-03-31 | 1995-04-18 | Makoto Machida | Composition of spent liquor from pulping process for antiviral medicine |
-
1971
- 1971-10-25 AU AU34928/71A patent/AU461558B2/en not_active Expired
- 1971-10-25 IL IL38003A patent/IL38003A/en unknown
- 1971-11-04 NL NL7115198A patent/NL7115198A/xx unknown
- 1971-11-08 GB GB5172671A patent/GB1345358A/en not_active Expired
- 1971-11-09 IE IE1414/71A patent/IE36030B1/en unknown
- 1971-11-11 DK DK552471A patent/DK132485C/en active
- 1971-11-12 BE BE775255A patent/BE775255A/en unknown
- 1971-11-12 BR BR007569/71A patent/BR7107569D0/en unknown
- 1971-11-15 ES ES397035A patent/ES397035A1/en not_active Expired
- 1971-11-15 FI FI713261A patent/FI51048C/en active
- 1971-11-15 ZA ZA717652A patent/ZA717652B/en unknown
- 1971-11-15 CH CH1655371A patent/CH557177A/en not_active IP Right Cessation
- 1971-11-15 CA CA127,705A patent/CA994241A/en not_active Expired
- 1971-11-15 FR FR7140790A patent/FR2113976B1/fr not_active Expired
- 1971-11-16 AT AT990271A patent/AT313468B/en not_active IP Right Cessation
- 1971-11-16 DE DE19712156915 patent/DE2156915A1/en active Pending
-
1974
- 1974-01-16 ES ES422331A patent/ES422331A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IL38003A0 (en) | 1971-12-29 |
DE2156915A1 (en) | 1972-05-31 |
ES422331A1 (en) | 1976-06-01 |
FI51048B (en) | 1976-06-30 |
DK132485C (en) | 1976-05-17 |
BE775255A (en) | 1972-03-01 |
AT313468B (en) | 1974-02-25 |
DK132485B (en) | 1975-12-15 |
FR2113976A1 (en) | 1972-06-30 |
GB1345358A (en) | 1974-01-30 |
IL38003A (en) | 1974-06-30 |
CH557177A (en) | 1974-12-31 |
IE36030B1 (en) | 1976-08-04 |
IE36030L (en) | 1972-05-16 |
AU3492871A (en) | 1973-05-03 |
ZA717652B (en) | 1972-10-25 |
CA994241A (en) | 1976-08-03 |
BR7107569D0 (en) | 1973-08-16 |
FI51048C (en) | 1976-10-11 |
AU461558B2 (en) | 1975-05-29 |
NL7115198A (en) | 1972-05-18 |
FR2113976B1 (en) | 1975-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES324152A1 (en) | Procedure for the obtaining of a fenilmercaptometanosulfonamida of fungytoxic effects. (Machine-translation by Google Translate, not legally binding) | |
ES315410A1 (en) | Procedure for the production of desamino-arg8-vasopresina. (Machine-translation by Google Translate, not legally binding) | |
ES397035A1 (en) | Antiinflammatory preparations | |
ES299388A1 (en) | Procedure for the production of a new polipepture and its derivatives (Machine-translation by Google Translate, not legally binding) | |
ES331182A1 (en) | A procedure for the preparation of epsilon-caprolactone and its alcohol derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES407523A1 (en) | Natiinflammatory agents | |
ES294357A1 (en) | Procedure for the obtaining of new nonapeptures (Machine-translation by Google Translate, not legally binding) | |
ES431083A1 (en) | Alanine derivatives and their production | |
ES329851A1 (en) | Procedure for the preparation of new antibiotics. (Machine-translation by Google Translate, not legally binding) | |
ES403003A1 (en) | Method of preparing 2-methoxy-n-n-ethylpyrrolidin-2-yl- methyl-5-sulphamoyl-benzamide | |
ES328594A1 (en) | A procedure for the preparation of eritromycin glutamate. (Machine-translation by Google Translate, not legally binding) | |
ES413274A1 (en) | A procedure for the preparation of an indenilactic acid derivative. (Machine-translation by Google Translate, not legally binding) | |
ES293226A1 (en) | Procedure for the preparation of a pigment based on the beta form of quinacridone (Machine-translation by Google Translate, not legally binding) | |
ES320392A3 (en) | Procedure for the obtaining of hormonal derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES319122A1 (en) | A procedure for preparing an antidyardaric complex of bismuto and chlorohidroxyquinoline. (Machine-translation by Google Translate, not legally binding) | |
ES274035A1 (en) | Procedure for the preparation of N-methyl-efedrine beta-canfosulfonate (Machine-translation by Google Translate, not legally binding) | |
ES407124A2 (en) | A procedure for obtaining a doxidicline salt. (Machine-translation by Google Translate, not legally binding) | |
ES411613A1 (en) | A procedure for the obtaining of N-isopropil-alpha-chloroacetanilida pura. (Machine-translation by Google Translate, not legally binding) | |
ES323030A1 (en) | Procedure for the obtaining of a hydrosoluble derivative of pirazolidine. (Machine-translation by Google Translate, not legally binding) | |
ES310184A1 (en) | Procedure for the preparation of a new derivative of pirazolidine-hexametilenimina with therapeutic properties. (Machine-translation by Google Translate, not legally binding) | |
ES314562A1 (en) | Procedure for the obtaining of halogeno-alcanos thiocarbamate. (Machine-translation by Google Translate, not legally binding) | |
ES263915A3 (en) | Procedure for obtaining hormones and vitamins, especially b 12 of slow effect via via injectable (Machine-translation by Google Translate, not legally binding) | |
ES352232A1 (en) | Procedure for the preparation of citrate decided of acetyle-2-dimethylamine etoxy-5-carvacrol. (Machine-translation by Google Translate, not legally binding) | |
ES416953A1 (en) | Oestradiol derivative and a process for its manufacture | |
ES311722A1 (en) | Procedure for the preparation of alpha-amino-propionic alpha substitute acid derivatives. (Machine-translation by Google Translate, not legally binding) |